35 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
Onset of Intramuscular (IM) Medications for Severe Agitation
Ketamine (2-5 mg/kg IM) 3-7m
Droperidol (5 mg IM) 5-10m
Midazolam
Medications for Severe Agitation ... Ketamine (2-5 ... #Onset #Agitation ... #Duration #Pharmacology ... #Table #Management
The Acute Care Opioid Table - For Emergency Providers

There are a hundred opioid tables out there,
Including ketamine ... , IN Ketamine ... #Opioid #Pain ... Dosing #Acute #Management ... #Table #Pharmacology
NSAIDs and GI versus CV risk

Follow www.instagram.com/rxnotes for more!

#pharmacology #comparison #cardiology #gi #nsaids #pain #medications #management
#pharmacology #comparison ... cardiology #gi #nsaids #pain ... #medications #management
Pain Assessment and Management Initiative (PAMI) - Ketamine Dosing

#Management #Pain #Pharmacology #Ketamine #Analgesia #Subdissociative #ExcitedDelirium #Doses
Pain Assessment ... and Management Initiative ... (PAMI) - Ketamine ... Dosing #Management ... #Pain #Pharmacology
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
Pain, Agitation, ... bradycardia • Ketamine ... No pharmacologic ... (Haldol) - No pharmacologic ... CriticalCare #diagnosis #management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicilliosis #IDSA ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... HumanPapillomavirus #IDSA ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... candida #mucosal #IDSA ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology